Management of Endometriosis

Sajal Gupta, Avi Harlev, Ashok Agarwal, Mitali Rakhit, Julia Ellis-Kahana, Sneha Parikh
In: SpringerBriefs in Reproductive Biology · 2015 · pp. 95–112 · doi:10.1007/978-3-319-18308-4_10 · W2278325633
book-chapter OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by claude@2026-06+body, 2026-06-07 ⓘ

Endometriosis treatments are pharmacological and surgical, aiming for symptom relief and fertility improvement as no cure currently exists.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-07 ⓘ

This chapter reviews management of endometriosis, describing treatment approaches in broad categories of pharmacological and surgical methods while emphasizing that the disease’s etiology is not fully established. It argues that because no current therapy can prevent or cure endometriosis, treatment is instead directed toward symptom relief and/or improving fertility outcomes, and that evaluation of options should consider effects on pain and infertility to reflect quality of life. A stated limitation is that the uncertain etiology means none of the available treatments can provide cure or prevention. This paper is centrally about endometriosis — it provides an overview of pharmacological and surgical treatment goals and evaluation criteria for symptom relief and fertility.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (100)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-06-14T06:15:46.576397+00:00
License: CC0 · commercial use OK